No significant differences in the expression of calreticulin, GRP78 and GRP94 in tumour compared to matched normal tissue were detected in samples from patients with good or poor outcome who received chemotherapy (Additional file 5: Figure S4A, C, D). This evidence concerns the gene HSP90B1 and neoplasm.